๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans

John Newman

Stock Analyst at Canaccord Genuity

(0.10)
# 4,885
Out of 5,189 analysts
984
Total ratings
36%
Success rate
-8.8%
Average return

Stocks Rated by John Newman

Incyte
Nov 17, 2026
Reiterated: Buy
Price Target: $152
Current: $114.63
Upside: +32.61%
Tango Therapeutics
Nov 17, 2026
Reiterated: Buy
Price Target: $46
Current: $21.73
Upside: +111.69%
Candel Therapeutics
Nov 13, 2026
Reiterated: Buy
Price Target: $25 → $13
Current: $5.04
Upside: +157.94%
Parabilis Medicines
Nov 13, 2026
Reiterated: Buy
Price Target: $39
Current: $27.44
Upside: +42.13%
BridgeBio Oncology Therapeutics
Nov 12, 2026
Reiterated: Buy
Price Target: $20
Current: $1.81
Upside: +1,004.97%
Tyra Biosciences
Nov 11, 2026
Reiterated: Buy
Price Target: $50
Current: $20.12
Upside: +148.51%
Allogene Therapeutics
Nov 10, 2026
Reiterated: Buy
Price Target: $14
Current: $0.6277
Upside: +2,130.36%
Atara Biotherapeutics
Nov 10, 2026
Reiterated: Buy
Price Target: $13
Current: $6.33
Upside: +105.37%
Compass Therapeutics
Nov 10, 2026
Reiterated: Buy
Price Target: $7
Current: $0.6882
Upside: +917.15%
Delcath Systems
Nov 10, 2026
Reiterated: Buy
Price Target: $21 → $27
Current: $18.79
Upside: +43.69%
Reiterated: Buy
Price Target: $1,175
Current: $920.69
Upside: +27.62%
Reiterated: Buy
Price Target: $40
Current: $33.26
Upside: +20.26%
Reiterated: Buy
Price Target: $18
Current: $2.14
Upside: +741.12%
Reiterated: Buy
Price Target: $29
Current: $16.12
Upside: +79.90%
Reiterated: Buy
Price Target: $132
Current: $80.96
Upside: +63.04%
Reiterated: Buy
Price Target: $22
Current: $1.24
Upside: +1,674.19%
Reiterated: Buy
Price Target: $29
Current: $4.92
Upside: +489.43%
Reiterated: Buy
Price Target: $8
Current: $1.09
Upside: +633.94%
Reiterated: Buy
Price Target: $9
Current: $0.7719
Upside: +1,065.95%
Reiterated: Buy
Price Target: $10
Current: $3.99
Upside: n/a
Reiterated: Buy
Price Target: $5
Current: $0.3501
Upside: n/a
Reiterated: Buy
Price Target: $6 → $300
Current: $4.58
Upside: n/a
Reiterated: Buy
Price Target: $43
Current: $6.14
Upside: n/a
Reiterated: Buy
Price Target: $52 → $44
Current: $27.60
Upside: n/a
Reiterated: Buy
Price Target: $7 → $3
Current: $0.0002
Upside: n/a
Reiterated: Buy
Price Target: $353.03
Current: $21.04
Upside: n/a
Reiterated: Buy
Price Target: $31
Current: $7.56
Upside: n/a
Reiterated: Buy
Price Target: $45
Current: $13.22
Upside: n/a
Reiterated: Buy
Price Target: $5
Current: $0.3369
Upside: n/a
Reiterated: Buy
Price Target: $14.35
Current: $9.24
Upside: n/a
Reiterated: Buy
Price Target: $20
Current: $0.84
Upside: n/a
Reiterated: Buy
Price Target: $31 → $6
Current: $1.01
Upside: n/a
Reiterated: Buy
Price Target: $8 → $5
Current: $37.04
Upside: n/a
Reiterated: Buy
Price Target: $10
Current: $14.70
Upside: n/a
Reiterated: Buy
Price Target: $12
Current: $13.00
Upside: n/a
Reiterated: Buy
Price Target: $10
Current: $6.99
Upside: n/a
Reiterated: Buy
Price Target: $6 → $60
Current: $0.40745
Upside: n/a
Reiterated: Buy
Price Target: $6 → $15
Current: $1.48
Upside: n/a
Reiterated: Buy
Price Target: $34
Current: $8.76
Upside: n/a
Reiterated: Buy
Price Target: $3
Current: $4.26
Upside: n/a
Reiterated: Hold
Price Target: $90
Current: $29.63
Upside: n/a
Reiterated: Buy
Price Target: $30
Current: $1.95
Upside: n/a
Reiterated: Buy
Price Target: $26
Current: $27.57
Upside: n/a
Reiterated: Buy
Price Target: $18
Current: $594.51
Upside: n/a
Reiterated: Hold
Price Target: $8 → $6
Current: $0.7852
Upside: n/a
Reiterated: Buy
Price Target: $201
Current: $230.26
Upside: n/a
Initiated Coverage: Buy
Price Target: $24
Current: $5.82
Upside: n/a
Downgraded: Hold
Price Target: $40 → $9
Current: $7.45
Upside: n/a
Rated: Buy
Price Target: $127
Current: $249.59
Upside: n/a
Downgraded: Sell
Price Target: $5
Current: $3.85
Upside: n/a
Reiterated: Sell
Price Target: n/a
Current: $72.11
Upside: n/a